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Evidence-based medicine aims to make clinical 
practice more scientific and empirically grounded in 
order to achieve safer, more consistent and cost-
effective care.1 It helps ensure that interventions are 
backed by evidence of sufficient quality to justify 
investment in implementation and scale-up. Since its 
introduction in the 1970s, the term ‘evidence-based 
intervention’ has moved from being an intellectual 
curiosity to a central component in conversations 
about health or behavioural interventions. There have 
been substantial successes with evidence-based 
medicine and policy development, but they are not 
without critics.2 
Globally, randomised controlled trials (RCTs) are 
increasingly seen as the gold standard of programme 
evaluation, representing the best way to determine 
whether new interventions are effective.3, 4 Evidence-
based medicine is built upon the foundation of the 
RCT. It is rare, particularly in clinical practice, for 
evidence other than that emanating from an RCT 
to be considered of sufficient evidentiary standard – 
despite the fact that a great deal of clinical practice 
remains based on professional experience and 
observation. Others argue that the ‘hegemony’ of the 
RCT marginalises intervention types that do not lend 
themselves to an RCT design.5  
In this article, we discuss the phases of scientific 
discovery and the research standards that some 
argue are necessary before scaling up interventions. 
We also outline the core characteristics of RCTs, 
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such as randomisation, efficacy and effectiveness, 
and discuss the benefits of using the RCT as the 
standard of intervention evaluation. Finally, we will 
juxtapose this with a discussion of the limitations of 
RCT and how other methods can be used as a way 
of testing interventions.   
How and why is evidence built?
Efficacy and effectiveness
If policymakers propose to invest in a violence 
prevention intervention (a parenting programme, a life 
skills curriculum, reducing access to alcohol)6 then 
one of the central questions should be: does that 
intervention achieve the outcomes that are expected 
of it, so that it will be a worthwhile investment of 
taxpayers’ money? The purpose of an efficacy trial is 
to answer precisely that question: did the intervention 
make a difference, and how sure can we be that it 
was the intervention (and not something else) that 
made the difference? This is a question of internal 
validity (see Table 1 for a summary of definitions). 
Internal validity is the extent to which bias and 
confounding variables that may unintentionally affect 
the results are kept to a minimum in the conduct of 
a trial. Efficacy trials emphasise internal validity, and 
answer the question: ‘Does this intervention work 
under optimal conditions?’ 
Effectiveness trials, by contrast, answer a different  
question: ‘Does this intervention work under “real 
world” conditions?’7 
Efficacy and effectiveness exist on a continuum. 
Taking part in research often involves procedures and 
commitments that are different from routine practice. 
It may not be possible for an intervention delivered 
under carefully controlled research conditions to be 
replicated under routine conditions. This presents 
a challenge to evaluating the impact of large-scale 
public health programmes.8 Limitations associated 
with how study participants are selected, participant 
characteristics and trial management may also affect 
the relevance and feasibility of interventions based 
on RCT research. For these reasons, there is debate 




The group of individuals who do not 
receive the treatment condition, against 
which the outcomes of the intervention 
can be compared.
Effectiveness
The extent to which a specific 
intervention, when used under ordinary 
circumstances, does what it is intended 
to do.
Efficacy 
The extent to which an intervention 




The extent to which the results can be 
generalised to populations beyond the 
trial. Are the results valid for populations 
in which the intervention was not 
originally tested?
Internal validity
This gives researchers the confidence 
to conclude that what they did in the 
study caused what they observed to 
happen, i.e., that the outcome is the 
result of the treatment. A research study 
with high internal validity lets you choose 
one explanation over another with a lot 




A group of participants allocated a 
particular treatment.
Selection bias
A systematic distortion of evidence 
that arises because people with 
certain important characteristics are 
disproportionately more likely to wind 
up in one condition. Although random 
assignment theoretically eliminates 
selection biases, a bias can still occur. 
Another common problem is bias in 
selection to the trial at all – not only to 
which arm of the trial.  
Generalisability 
Related to issues of efficacy and effectiveness, 
another important question is whether the 
intervention will work with a different group of people. 
If a parenting programme was tested in Soweto 
with Setswana speakers, will it also work with 
isiZulu speakers in Ixopo, and Afrikaans speakers 
in Eldorado Park? This question – one of external 
validity, or generalisability – is crucial if policymakers 
wish to roll the programme out widely (see Box 1). 
If it was established as effective in one place, will it 
remain effective when taken to other places?
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Efficacy and effectiveness are linked to the concept 
of generalisability. When a trial is conducted in an 
ideal setting with all factors and variables being 
controlled (as far as is possible) by the researcher, it 
may lack a measure of generalisability. Characteristics 
of those enrolled in a study (e.g. sex, age, severity 
of the disease, racial groups) are primary factors 
in generalisability.10 For example, a study of a 
counselling intervention targeted at women may not 
necessarily generalise to men or children.  
Geographic settings (urban versus rural) and health 
care systems can also be significant factors,11 
particularly when something more complex than 
a drug (e.g. screening programmes, behavioural 
therapy) is being tested. Multiple factors 
determine the external validity (i.e. generalisability 
or applicability) of studies, including of RCTs: 
characteristics of those taking part in the programme 
and in the study, the problem under investigation, 
costs, compliance, co-morbidities and concomitant 
interventions. Also, certain aspects of study design – 
eligibility criteria, study duration, mode of intervention, 
outcomes, adverse events assessment, or type of 
statistical analysis – greatly influence the degree of 
generalisability.12
Phases of scientific discovery
For scientific evidence to be useful to policymakers, 
they need to distinguish which research and types 
of evidence will be most useful to them, which 
means understanding how new interventions are 
developed and taken to scale. Thornicroft and 
colleagues13 propose a five-phase schema to 
understand research terminology and the discovery, 
development, dissemination and implementation of 
new interventions.   
The starting point for any scientific discovery (Phase 
0) is exploring relevant theories, generating 
hypotheses about how interventions might work, and 
conducting fundamental epidemiological research to 
understand factors driving the problem. These 
understandings can then be transferred to develop 
interventions. Phase 1 includes early studies that aim 
to identify key components of an intervention. In 
Phase 2, investigators include efficacy studies 
(usually an RCT) that assess whether the intervention 
is effective under ideal conditions.14 After efficacy of 
the intervention has been established, investigators 
shift the focus to studies in routine clinical conditions, 
to investigate intervention effectiveness in the real 
world (Phase 3). These studies may be implemented 
in target populations over a longer time period to 
identify other effects. Scaling up interventions that are 
scientifically proven and applicable to the everyday 
procedures of violence prevention practice can be 
challenging, and form Phase 4. 
These five phases work together with standards 
set by the Institute of Medicine,15 the Society 
for Prevention Research and other communities 
of researchers16 to provide a framework for 
understanding what is good and sufficient evidence 
for establishing that an intervention should be 
implemented as a matter of policy. According to these 
standards, scale-up or countrywide implementation 
would be dependent on the completion (for each 
intervention) of (a) two high-quality efficacy RCTs, 
(b) two high-quality effectiveness RCTs, followed by 
(c) dissemination research that has established that 
the intervention can be delivered with fidelity to the 
model, and (d) information about the intervention’s 
costs (see Figure 1 for a summary of these stages).  
In addition, policymakers need to make decisions 
about how to weigh the evidence when considering 
implementation.18 Victora and colleagues have 
proposed three levels of evidence to guide 
decisions:19
•	 Adequacy	evidence	–	was	the	intervention	
implemented and found to be successful?
•	 Plausibility	evidence	–	were	the	changes	found	in	
adequacy evidence shown to not be due to other 
influences?
•	 Probability	evidence	–	were	the	changes	observed	
not due to chance? For probability evidence, RCTs 
are needed.
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Why randomised controlled trials, 
and where do they fit in?
RCTs are most successful in achieving high levels of 
internal validity and are thus considered the standard 
method for efficacy and effectiveness trials.20 RCTs 
have a simple intention: to compare what would have 
happened in one group if the intervention was not 
received, with what happens when the intervention 
is received in another, otherwise equivalent, group. 
At the start (before the intervention is provided) 
those two groups must be equal in terms of their 
experience of the problem and characteristics that 
affect their experience. For instance, if the problem 
being addressed is child aggression, at the start both 
groups of children must be equal on a measure of 
child aggression, and have the same spread of age 
and gender of children (since older children and boys 
tend to be more aggressive, one must have equal 
numbers of older and younger children, and of boys 
and girls, in both groups). A defining characteristic 
of the RCT is that research participants who receive 
the intervention and the participants who make up 
Figure 1: Phases of scientific discovery and research standards
Phase 0: Basic science
Phase 1: Initial efficacy trials
Efficacy trials 
(ideal conditions)
Clear operationalisation of 
intervention
Use of most rigorous 
research design possible
Clear specification of 
sample
Use of valid outcome 
measures
Impact of practical public 
health value
Impacts maintained at least 
six months after end of 
intervention
Replication of programme 




Effectiveness trials must 
meet all of the standards 
for efficacy trials, plus:
•	 Programme	
operationalised in 







exposure, integrity and 
implementation
•	 Real-world	target	
population and sampling 
methods given
Dissemination research
Evidence must meet 
standards of effectiveness
Evidence must be available 
that intervention can be 
delivered with fidelity to 
model tested
Cost information must be 
available
Intervention must be 
supported by monitoring 
and evaluation tools
Phase 1 Phase 2 Phase 3 Phase 4
the control group (i.e. those who do not receive the 
intervention) are randomly assigned to those groups 
(hence randomised controlled trial). With a sufficiently 
large sample, randomisation ensures fair distribution 
of the problem and related characteristics across 
the two groups. This capacity of RCTs to ensure a 
fair comparison between intervention and control 
groups is a particular strength, as it allows the most 
accurate possible estimate of what would have 
happened if the intervention group had not received 
the intervention.21 Given an adequate sample size, 
the RCT typically surpasses all other designs in terms 
of its statistical power to detect the predicted effect 
of the intervention.22 
However, randomisation may face opposition from 
policymakers and practitioners, who may believe 
in the value of an intervention for certain individuals 
or groups, often regardless of its actual evidence 
base, and therefore oppose random allocation.23 For 
instance, in one trial – testing a substance abuse 
intervention in a community health centre, with 
the hope that it would reduce substance-related 
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aggression as well as substance misuse and HIV risk 
behaviours – nurses in the health centre tried to refer 
patients to the intervention group in the belief that the 
intervention would help them, regardless of the fact 
that the intervention had yet to be tested. However, 
only after the intervention has been tested in a high-
quality evaluation can we have any certainty that it 
is effective. It is entirely possible that the intervention 
could have very little effect (as was in fact the case 
for that substance abuse intervention)24 or even do 
harm. Famously, a substance abuse intervention 
that was rolled out widely in US high schools cost an 
enormous amount and made no difference to those 
receiving the programme: they were just as likely to 
use drugs and alcohol as those who did not.25 Even 
more concerning, a common-sense delinquency 
prevention programme – taking youth at risk into 
prisons so that convicted offenders could scare 
them away from their lives of delinquency – turned 
out to increase offending in the young people, rather 
than deterring them.26 In the long run, therefore, 
randomly assigning people to groups – knowing that 
people in need may end up in the control group and 
receive nothing – is more ethical than not using either 
random assignment or a control group,27 providing of 
course that implementers truly do not know what the 
outcome of the intervention will be. 
In the case of difficulties with, or objections to, 
individual randomisation, one possible solution is to 
use a cluster RCT, with the group (cluster) rather than 
the individual as the unit of randomisation. Members 
of a cluster (e.g., village, clinic, community) who 
might naturally influence one another or be affected 
as a group by prevailing conditions are clustered 
together and then randomised.28  
RCTs are one of the most reliable methods of 
determining the effects of a treatment, because 
they are high in internal validity. However, they – like 
other trial designs that are used under very particular 
conditions – are not necessarily high in external 
validity. For instance, RCTs are often conducted 
with specific types of people under highly controlled 
conditions, and making inferences to the wider 
population may be difficult.29 Recruitment often 
employs stringent eligibility criteria to minimise 
adverse events and potential non-responders. 
Some trials screen up to 68 people for each person 
enrolled.30 In many settings, RCTs emphasise 
standardised interventions that might be too rigid 
when they need to be tailored for local population 
needs or other settings.31 There are also concerns 
about the extent to which trials conducted in high-
income settings apply to low- and middle-income 
countries (LMIC).32 It cannot be assumed that 
there will be a universal response to an intervention 
across contexts, since a delivery system (such as a 
health system) in one context may have particular 
capacity for training, contact between health workers, 
supervision and population differences that will 
determine the effect of an intervention and to what 
extent it can be successfully implemented,33 while 
delivery systems in other contexts may have different 
characteristics.  
Other limitations of RCTs are that they are time- 
and energy-intensive as well as expensive, and 
may not be feasible for all interventions or settings. 
These threats to external validity limit the potential 
generalisation of the research results, an important 
consideration given the increasing emphasis on the 
translation of research results into practice.34 
One common response to this is to try to have tests 
of programmes explicitly examine ‘what works for 
whom, in what circumstances, in what respects 
and how’, an approach called ‘realist evaluation’.35 
This makes sure that the mechanisms that actually 
produced the change are clearly specified and 
consistent with the best available scientific theory 
and evidence, providing policymakers with the very 
detailed and practical understanding of a programme 
that is necessary before deciding whether that 
programme may be suitable for their context or not.36
Case study: Box 1
Cognitive therapy-based intervention using 
community health workers (Pakistan)
Rahman and colleagues implemented a 
cognitive behavioural intervention in which 
local health workers, known as Lady Health 
Workers, delivered a mental health intervention 
component.37 One of the difficulties with 
implementing health interventions is the lack 
of adequately trained professionals in most 
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LMIC, especially in the case of mental health 
interventions where, in some countries, the 
treatment gap approaches 90%.38 In Pakistan, 
Lady Health Workers are women who have 
completed secondary school and are trained to 
deliver preventive maternal, neonatal and child 
health care and education in the community. 
Lady Health Workers provide services to about 
80% of the rural population of Pakistan. A 
cluster RCT was conducted with depressed 
women in their third trimester of pregnancy. 
Lady Health Workers were trained to deliver 
the intervention, while in control clusters Lady 
Health Workers who had not been trained 
in mental health made an equal number of 
visits to depressed women. The intervention 
halved the rate of prenatal depression in the 
intervention group. In addition, women receiving 
the intervention had better overall functioning 
and less disability up to a year later. Other health 
benefits included fewer episodes of diarrhoea 
and higher levels of immunisation in the 
intervention group.  The intervention is a pivotal 
one because it is not dependent on a new or 
separate mental health workforce for its delivery. 
Rahman and colleagues argue that evidence 
of this sort is crucial in order to convince LMIC 
policymakers of the importance of integrating 
interventions such as these into the existing 
health system. This study is frequently used as 
evidence for how mental health interventions 
can be delivered by community health workers 
and how they can feasibly be delivered at 
scale – and this is undoubtedly true. There are 
a number of potential problems, however, with 
using evidence such as this in countries other 
than Pakistan. One is the lack of similar existing 
cadres of functioning community health workers 
such as the Lady Health Workers. Most LMIC 
do not have such an extensive workforce, and 
when they do there are significant problems with 
management, care delivery and supervision.39 In 
addition, it is likely that the prevailing cultural and 
contextual conditions in this region of Pakistan 
(such as maternal seclusion after birth, and not 
being permitted visitors unless they are family) 
may limit the external validity of these data.  
Alternatives to the RCT
Aside from external validity, there are many other 
reasons why an RCT might not be the best method 
to assess intervention effectiveness.  Reasons might 
include the following: when the impact is likely to be 
large, making randomisation potentially unethical; 
when the timing of the impact is likely to be long, 
making follow-up and assessment too expensive; 
or in a situation where a national roll-out of an 
intervention (such as in the Integrated Management 
of Childhood Illness [IMCI]) has already occurred, 
because a policy (or ideological) decision has been 
made about implementing a particular intervention.40 
In these cases, random allocation may not be 
possible. But there are alternatives, for instance:
•	 In	consultation	with	policymakers,	it	might	be	
possible to use a ‘stepped-wedge’ design, 
where implementing the intervention in certain 
areas is delayed – here the order of receiving the 
intervention is randomised.  
•	 In	some	cases,	there	may	be	a	clear	cut-off	that	
defines who gets the programme and who does 
not. For instance, the government may decide that 
only those whose household income is below a 
certain level will get the programme. Bonell and 
colleagues argue that in cases such as this a 
‘regression-discontinuity’ analysis can be used, 
which examines the association between the 
outcome of the intervention and the measure 
of need.41 Under certain conditions (such as a 
very large sample size), regression discontinuity 
designs can be just as powerful as RCTs. This 
approach was used to evaluate pre-kindergarten 
(the equivalent of Grade R) in Tulsa, Oklahoma.42 
All children had to attend pre-kindergarten, and so 
randomisation was impossible – but the regression 
discontinuity design used in the evaluation 
provided convincing evidence that the city’s 
investment in pre-kindergarten led to worthwhile 
outcomes for children.43
•	 Another	alternative	design	is	what	is	known	
as non-random quantitative assignment of 
treatment.44 In this design, participants are 
assigned to a treatment group based on need or 
merit, rather than random assignment. A good 
example of this is the school lunch programme in 
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the United States (US) where household income 
(below the poverty line) is used to assign children 
to receiving school lunches.  Statistical analysis 
then models the functional relationship between 
the quantitative assignment variable (household 
income level) with the known outcome variables 
(such as health, concentration at school and 
academic achievement).45
•	 A	similar	design	is	a	non-randomised	cohort	study	
where two groups are followed over time with 
baseline assessments, intervention is delivered 
to one group and not the other, and follow-up 
interviews are conducted to assess outcome. In 
this case two neighbourhoods can be chosen 
and matched as closely as possible. Without 
randomisation, ascribing change solely to the 
intervention is difficult, but if changes are in the 
hypothesised direction, policymakers might have 
sufficient evidence of effectiveness to implement.  
•	 A	final	option	is	a	repeated	cross-sectional	survey	
(or interrupted time series), which permits the 
evaluation of secular trends.46 These are, however, 
expensive and prone to selection bias, although 
if routinely collected administrative data is of 
sufficient quality they can be very helpful and are 
relatively cheap, since they are gathered routinely 
and not just for the purposes of the evaluation. 
For instance, crime statistics collected by the 
US Federal Bureau of Investigation (FBI) were 
combined with data collected by the television 
industry to explore whether the introduction 
of television had increased violent crime in the 
US. A time series design was used to clearly 
demonstrate  that violent crime had not increased, 
but that theft had increased as television was 
introduced.47
The point is that programmes that are to be rolled 
out widely (and where people cannot be randomised) 
must still be evaluated, using the best possible 
research design.
Scale-up and ‘when is there 
enough evidence’
Attempts have been made to rank the levels 
of evidence in order to assist policymakers in 
making decisions about evidence-based policy 
and practice. Within this framework the design 
and conduct of the research is categorised in 
terms of strength of evidence. In one of the most 
widely-used frameworks, there are five levels of 
evidence.48 These range from level 5, the lowest level 
of support (expert opinion), to level 1, the highest 
– a meta-analysis of randomised controlled trials 
addressing the same problem, which can provide 
clarity on both whether the proposed intervention 
works and under what conditions. If many studies 
carried out in different settings together result in 
the conclusion that the programme generally has 
an effect, then one can have greater confidence 
that it will work in a new setting. Each of the other 
‘levels’ of evidence (levels 2, 3, 4) of experimental 
design can then be seen as increasing the potential 
for the outcomes to be confounded by factors that 
are external to the experiment, or an inherent part 
of it, and are therefore weaker and less useful for 
making policy decisions.49 Olds has argued that if 
policy and practice recommendations (in his case, 
for parenting interventions) are based on RCTs that 
meet the most stringent RCT requirements, they will 
have the greatest chance of being efficacious when 
disseminated and implemented at scale.50  
Weaker evaluations mean that there is less chance 
that programmes will be effective when implemented 
widely and under real-world conditions. In addition, 
even implementing an established programme with 
a strong evidence base in a new setting runs the risk 
of changing some of the fundamental characteristics 
that led to programme success in the earlier settings 
(see Box 2). For this reason, every programme, no 
matter how strong its evidence base, should be 
evaluated when it is moved to a new setting.51 For 
instance, when Strengthening Families (a substance 
misuse prevention programme shown to be effective 
in one setting) was implemented in a different 
setting (in the US – the same country in which it was 
originally tested) it was much appreciated by the 
families receiving it, but made no difference to their 
children’s behaviour.52 In cases where a programme 
is moved, but a full evaluation is not possible, 
some basic monitoring (for instance, comparing 
children’s behaviour at the start and at the end of the 
programme) should be carried out.
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Case study: Box 2
Nutrition and psychosocial stimulation and 
mental development of stunted children 
(Jamaica)
Grantham-McGregor and colleagues 
implemented an intervention study of nutritional 
supplementation and psychosocial stimulation of 
stunted children.53 A total of 129 children were 
randomly assigned to four groups: nutritional 
supplementation only; psychosocial stimulation 
only; nutritional plus psychosocial stimulation; 
and a control group. There was also a group 
of matched non-stunted children. Community 
health aides delivered the intervention. The 
results of the study were compelling and showed 
how nutritional supplementation had a beneficial 
effect on stunted children’s mental development. 
Importantly though, the treatment effects 
were additive, with the combined intervention 
(nutritional plus psychosocial stimulation) being 
significantly more effective than either of the 
stand-alone interventions.54 This study is one 
of the most frequently cited papers in the child 
development literature and has had a significant 
impact on the design of interventions in many 
LMIC.55 A recent 20-year follow-up on the 
same sample found that the earnings of the 
stimulation group were 25% higher than those 
of the control group and had caught up to the 
earnings of a non-stunted comparison group.56 
This study is unquestionably an important 
and seminal one. There are, however, two 
particular issues that should be borne in mind 
when using this data to inform scale-up or 
interventions in other countries. The first is the 
small sample size – only 32 children received the 
supplementation and psychosocial intervention. 
The second has to do with the relevance of 
this data (particularly the long-term economic 
finding) to most other LMIC. Jamaica has a very 
high rate of pre-school attendance, unlike most 
LMIC. The early impact of the supplementation 
and psychosocial stimulation is an important 
and compelling finding, but it is possible that 
part of the explanation for the long-term benefit 
of the early intervention is the additive booster 
benefit of a high enrolment in pre-school. It is 
possible that in countries where enrolment in 
crèches or pre-school is very low, the benefits 
of the early intervention may disappear over 
time. This is of course an empirical question 
and should be tested, but the issue is testament 
to the limitations of RCTs and how longitudinal 
assessment in many countries is vital in order to 
make meaningful policy decisions.  
Conclusions
Where does this leave policymakers? There are 
several principles to apply. Firstly, if a meta-analysis 
finds that a programme is effective, it is likely to be 
a good investment. At that point, experts should 
be commissioned to ensure cultural acceptability 
in the new setting, and to evaluate it – preferably 
using an RCT, to ensure good estimation of effect.  
Secondly, if there is no meta-analysis, one might 
commission experts to conduct one if enough 
RCTs testing the programme have been carried 
out. Thirdly, if a programme has shown promise in 
one RCT or in other forms of evaluation, conduct 
at least two RCTs before considering rolling the 
programme out. Programmes that are grounded 
in strong theory and have clear manuals to guide 
them are more likely to be effective than those that 
do not meet these criteria.57 If programmes must 
be taken to scale immediately, there is no reason 
not to phase them in carefully in a cluster RCT. 
For instance, the government of the Democratic 
Republic of the Congo has invested in a programme 
aimed at improving children’s numeracy, literacy and 
socio-emotional well-being. Schools were clustered 
together in clusters of three to six schools, with 
clusters randomly assigned, either to receive the new 
programme immediately or to be allocated to the 
control group, which will receive the programme at a 
later date. This allows for the programme to be tested 
in a thorough cluster RCT, at a level approaching 
scale, achieving two goals for policymakers: (1) 
making a potentially effective programme available to 
many children, while (2) ensuring that it is rigorously 
tested under real-world conditions, before scale is 
completely reached.58  
In this article we have argued that policymakers 
should consider evaluation of programmes an 
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essential investment, as part of their responsibility 
to taxpayers, to ensure that public funds are wisely 
invested. We have discussed how RCTs are very 
powerful designs but may not always be possible, 
and have a number of limitations. Given this, we 
have suggested a number of alternative designs and 
approaches to evaluation that can help policymakers 
decide on which programmes might work best, 
and how to assess them in new settings. That 
policymakers should draw on the strongest possible 
evidence, and that programmes should be monitored 
and evaluated, are, however, beyond question.
To comment on this article visit 
http://www.issafrica.org/sacq.php
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